Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / COM
-
Number of holders
-
21
-
Total 13F shares, excl. options
-
1.09M
-
Shares change
-
-44.4K
-
Total reported value, excl. options
-
$4.16M
-
Value change
-
+$1.13M
-
Put/Call ratio
-
5.31
-
Number of buys
-
16
-
Number of sells
-
-8
-
Price
-
$3.83
Significant Holders of Acurx Pharmaceuticals, Inc. - COM (ACXP) as of Q4 2023
31 filings reported holding ACXP - Acurx Pharmaceuticals, Inc. - COM as of Q4 2023.
Acurx Pharmaceuticals, Inc. - COM (ACXP) has 21 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.09M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (406K shares), Prospect Financial Services LLC (255K shares), GEODE CAPITAL MANAGEMENT, LLC (112K shares), BlackRock Inc. (63.1K shares), OSAIC HOLDINGS, INC. (57.3K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (53.6K shares), STATE STREET CORP (28.6K shares), TD Waterhouse Canada Inc. (18.7K shares), NORTHERN TRUST CORP (17.2K shares), and MORGAN STANLEY (16.2K shares).
This table shows the top 21 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.